Article Text

Download PDFPDF
Trends in the uptake and delivery of smoking cessation services to smokers in Great Britain
  1. John Britton1,
  2. Sarah Lewis2
  1. 1Division of Epidemiology and Public Health, University of Nottingham, City Hospital, Nottingham, UK
  2. 2Division of Respiratory Medicine, University of Nottingham, City Hospital
  1. Correspondence to:
 Professor J Britton
 Division of Epidemiology and Public Health, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Smoking kills more people than any other avoidable factor in the UK, and smoking cessation interventions are among the most cost effective treatments in medicine.1 Guidelines recommending routine implementation of smoking ascertainment and cessation in clinical practice were first published in the UK in 1998,2 and in the same year the UK government allocated funding to establish specialist smoking cessation services throughout the National Health Service.3 Since 2001 the antismoking drug bupropion and all nicotine replacement therapy (NRT) products have been available on NHS prescription, and their use supported by the National Institute for Clinical Excellence.4 The strong message of these policy developments is that advising smokers to quit, and providing behavioural and therapeutic cessation support, should by now be a standard component of medical practice. The recent Omnibus survey of Great Britain5 provides an opportunity to discover if this is indeed the case.


The Omnibus survey …

View Full Text


  • Funding: none.

  • Competing interests: none declared.

Linked Articles